Marché de la technologie de perfusion médicale – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00019844
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 173
Buy Now

Le marché de la technologie de perfusion médicale devrait atteindre 962,60 millions de dollars américains d'ici 2027, contre 707,10 millions de dollars américains en 2019. Le marché devrait croître à un TCAC de 4,1 % de 2020 à 2027.



La portée du marché de la technologie de perfusion médicale comprend la technique, le type d'organe, le composant et la région. Le marché de la technologie de perfusion médicale, basé sur la région, est segmenté en Amérique du Nord, en Europe, en Asie-Pacifique, au Moyen-Orient et en Afrique et en Amérique du Sud et centrale. Le rapport offre des informations et une analyse approfondie du marché de la technologie de perfusion médicale en mettant l'accent sur divers paramètres tels que les tendances du marché, les progrès technologiques, la dynamique du marché et l'analyse du paysage concurrentiel des principaux acteurs du marché à travers le monde. Il comprend également une analyse d'impact du COVID-19 dans toutes les régions.



Régions lucratives pour le marché de la technologie de perfusion médicale




Aperçu du marché



Instruments de perfusion pour les activités de recherche cellulaire



L'augmentation des maladies chroniques et les avantages des applications de la biotechnologie stimulent considérablement les activités de recherche cellulaire. Les tests cellulaires jouent un rôle essentiel dans la compréhension de divers défis de la biologie des organismes vivants, tels que la signalisation cellulaire, la prolifération, l'apoptose, la génétique cellulaire, la neurologie et le cancer.



Les tests cellulaires sont largement menées dans les industries pharmaceutiques et biotechnologiques, les instituts de recherche et les instituts de recherche universitaires. Les industries pharmaceutique et biopharmaceutique utilisent des tests cellulaires pour commercialiser efficacement un médicament.



Les tests cellulaires sont également largement effectués par les organismes de recherche sous contrat pour les études d'essais cliniques et d'autres processus. Les maladies chroniques telles que le cancer et d'autres études liées à la génétique accélèrent la demande d'études cellulaires. Par exemple, Charles River propose des services pour les tests à base de cellules primaires humaines. Selon un article publié par la société, les développements dans les tests cellulaires devraient se poursuivre à l'avenir. De plus, la société déclare que les tests cellulaires sont utiles dans la découverte de médicaments, car la corrélation in vitro à in vivo joue un rôle vital dans le développement de médicaments. Ainsi, l'augmentation des activités de recherche cellulaire est susceptible de stimuler le marché de la technologie de perfusion médicale au cours de la période de prévision.



Aperçus basés sur la technique



Basé sur la technique, le marché de la technologie de perfusion médicale est segmenté en machine à perfusion hypothermique et machine à perfusion normothermique. Le segment de perfusion de machine hypothermique détenait une plus grande part du marché en 2019. Cependant, le segment de perfusion de machine normothermique devrait enregistrer un TCAC plus élevé de 4,4 % sur le marché au cours de la période de prévision.




Global Marché de la technologie de perfusion médicale, par technique - 2019 et 2027




Informations basées sur le type d'organe



Selon le type d'organe, la perfusion médicale Le marché de la technologie est segmenté en cœur, poumon, rein et foie. Le segment rénal détenait la plus grande part du marché en 2019. Cependant, on estime que le segment cardiaque a enregistré le TCAC le plus élevé de 4,8 % sur le marché au cours de la période de prévision.




Basé sur les composants Insights



Sur la base des composants, le marché de la technologie de perfusion médicale est segmenté en pompes de perfusion, oxygénateurs, machines cœur-poumon, systèmes de surveillance, canules et autres. En 2019, le segment des oxygénateurs détenait la plus grande part de marché, par composant. En outre, le segment devrait également croître au rythme le plus rapide au cours des prochaines années en raison du nombre croissant de chirurgies cardiovasculaires, de transplantations hépatiques et de transplantations rénales.



Perspectives stratégiques



Les stratégies inorganiques telles que les partenariats et les fusions et acquisitions sont couramment adoptées par les entreprises pour répondre à l'évolution de la demande des clients et maintenir leur marque à travers le monde. Les acteurs du marché opérant sur le marché de la technologie de perfusion médicale adoptent également des stratégies organiques telles que le lancement et l'expansion de produits pour étendre leur empreinte et leur portefeuille de produits dans le monde entier ainsi que pour répondre à la demande croissante.



Par technique



< ul>
  • Perfusion par machine hypothermique

  • Perfusion par machine normothermique



  • Par type d'organe




    • Cœur

    • Poumon

    • Rein

    • Foie

    • Autres



    Par composant




    • Pompes à perfusion

    • Oxygénateurs

    • Machines cœur-poumon

    • Systèmes de surveillance

    • Canules

    • Autres
    • Par géographie




      • Amérique du Nord

        • États-Unis

        • Canada

        • Mexique


      • Europe

        • France

        • Allemagne

        • Italie

        • Royaume-Uni

        • Espagne
        • Reste de l'Europe


      • Asie-Pacifique (APAC)

        • Chine

        • Inde

        • Sud Corée

        • Japon

        • Australie

        • Reste de l'APAC


      • Moyen-Orient et Afrique (MEA)< ul>
      • Afrique du Sud

      • Arabie saoudite

      • EAU

      • Reste de la MEA


    • Sud et Amérique centrale (SCAM)

      • Brésil

      • Argentine

      • Reste de SCAM




    Profils de la société




    • Getinge AB

    • Medtronic

    • LivaNova PLC

    • XVIVO Perfusion

    • Terumo Cardiovascular Systems Corporation

    • OrganOx Limited

    • Waters Medical Systems

    • TransMedics

    • Systèmes de récupération d'organes

    • XENIOS AG
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What are Medical Perfusion Technology?

    Perfusion is the passage of fluid through the circulatory system or lymphatic system to an organ or a tissue, usually referring to the delivery of blood to a capillary bed in tissue. Perfusion is measured as the rate at which blood is delivered to tissue, or volume of blood per unit time (blood flow) per unit tissue mass. During major surgery, perfusion must be maintained and managed by the health professionals involved, rather than left to the body's homeostasis alone.

    What are the driving factors for the Medical Perfusion Technology market across the globe?

    Key factors that are driving the market are rising prevalence of cardiovascular diseases, significant growth of pharmaceutical and biotechnology industries, rising need for the organ transplantation and rising cell-based research activities. However, challenging factors such as expensive organ transplant surgeries and limited numbers of donors for organ transplant surgeries are likely to show negative impact for the market in few years ahead.

    What is the cost of Medical Perfusion Technology?

    The costs of the medical perfusion technology are much higher, and they may cost US$ 1,0000–5,0000, or more, per software. The cost may also differ from product to product types.

    The List of Companies - Medical Perfusion Technology Market

    1. Getting AB
    2. Medtronic              
    3. LivaNova PLC        
    4. Terumo Corporation          
    5. XVIVO Perfusion                 
    6. OrganOx Limited                 
    7. Waters Medical Systems LLC          
    8. TransMedics         
    9. Organ Recovery Systems                 
    10. Xenios AG - a Fresenius Medical Care company

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports